FibroGen Inc (FGEN)
0.40
+0.05
(+13.09%)
USD |
NASDAQ |
Dec 20, 16:00
0.4048
0.00 (0.00%)
After-Hours: 20:00
FibroGen Profit Margin (Quarterly): -36.87% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 14.22% |
| Arbutus Biopharma Corp | -1.47K% |
| GlycoMimetics Inc | -- |
| Cidara Therapeutics Inc | -- |
| Cue Biopharma Inc | -259.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -33.69% |
| Gross Profit Margin (Quarterly) | 88.57% |
| Operating Margin (Quarterly) | 3.83% |
| Return on Net Operating Assets | -62.90% |